Condition (MeSH)
Purpura Fulminans
ClinicalTrials.gov lists 3 trials for Purpura Fulminans or a narrower condition beneath it. Jinnah Postgraduate Medical Centre has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Rows recorded per section
3 sections measured, none recorded · 1 not measured yet · 1 not computed
3 of the 3 trials are tagged with Purpura Fulminans itself; the rest are tagged with a narrower condition beneath it.
When did Purpura Fulminans trials start? (3)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Observational
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2020 | 1 |
| 2017 | 1 |
| 2016 | 1 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 3 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Purpura Fulminans trials in? (1)
Shown in this order: phase order.
| Phase | Trials |
|---|---|
| Observational | 3 |
How many Purpura Fulminans trials are recruiting? (1)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Completed | 3 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Purpura Fulminans trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Jinnah Postgraduate Medical Centre | 1 |
Which serious adverse events do Purpura Fulminans trials report? (1)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Visual Nerve Damage | 1 | 1 |
Which publications cover Purpura Fulminans? (4)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Long-term Quality of Life in Adult Patients Surviving Purpura Fulminans: An Exposed-Unexposed Multicenter Cohort Study. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2019 | Yes |
| Clinical spectrum and short-term outcome of adult patients with purpura fulminans: a French multicenter retrospective cohort study. | Intensive care medicine | 2018 | Yes |
| [Sepsis-associated Purpura Fulminans International Registry--Europe (SAPFIRE)]. | Medizinische Klinik, Intensivmedizin und Notfallmedizin | 2014 | Yes |
| Assessment of the interplay between blood and skin vascular abnormalities in adult purpura fulminans. | American journal of respiratory and critical care medicine | 2013 | Yes |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.